“Making covid-19 vaccines widely available is key to getting people vaccinated and bringing the pandemic to an end,” said Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research. “This change should make this vaccine more widely available to the American public by facilitating the ability of vaccine providers, such as community doctors’ offices, to receive, store and administer the vaccine.”